EBDB, also known as 1,3-benzodioxolyl-N-ethylbutanamine, 3,4-methylenedioxy-α,N-diethylphenethylamine, or ethyl-J, is a psychoactive drug of the phenethylamine, phenylisobutylamine, and MDxx families.[1][2][3] It is the N-ethyl analogue of BDB (J) and the α-ethyl analogue of MDEA.[1]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists EBDB's minimum dose as 90 mg orally and its duration as unknown.[1] It produced few to no effects at the tested doses.[1]

Chemistry

Synthesis

The chemical synthesis of EBDB has been described.[1]

See also

References

  1. 1 2 3 4 5 6 7 Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. Ethyl-J Entry in PiHKAL
  2. ↑ Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
  3. ↑ Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.
allikas: https://en.wikipedia.org/wiki/1,3-Benzodioxolyl-N-ethylbutanamine